168 related articles for article (PubMed ID: 6170740)
1. Reversal of experimental delayed cerebral vasospasm by angiotensin-converting enzyme inhibition.
Gavras H; Andrews P; Papadakis N
J Neurosurg; 1981 Dec; 55(6):884-8. PubMed ID: 6170740
[TBL] [Abstract][Full Text] [Related]
2. Reversal of experimental acute cerebral vasospasm by angiotensin converting enzyme inhibition.
Andrews P; Papadakis N; Gavras H
Stroke; 1982; 13(4):480-3. PubMed ID: 6179264
[TBL] [Abstract][Full Text] [Related]
3. Alacepril, an angiotensin-converting enzyme inhibitor, prevents cerebral vasospasm in subarachnoid hemorrhage model in rats.
Honda Y; Minato H; Fujitani B; Masuda Y; Hosoki K
Methods Find Exp Clin Pharmacol; 1997 Dec; 19(10):699-706. PubMed ID: 9542720
[TBL] [Abstract][Full Text] [Related]
4. Systemic administration of an inhibitor of endothelin-converting enzyme for attenuation of cerebral vasospasm following experimental subarachnoid hemorrhage.
Caner HH; Kwan AL; Arthur A; Jeng AY; Lappe RW; Kassell NF; Lee KS
J Neurosurg; 1996 Nov; 85(5):917-22. PubMed ID: 8893732
[TBL] [Abstract][Full Text] [Related]
5. Prevention and reversal of cerebral vasospasm by an endothelin-converting enzyme inhibitor, CGS 26303, in an experimental model of subarachnoid hemorrhage.
Kwan AL; Bavbek M; Jeng AY; Maniara W; Toyoda T; Lappe RW; Kassell NF; Lee KS
J Neurosurg; 1997 Aug; 87(2):281-6. PubMed ID: 9254094
[TBL] [Abstract][Full Text] [Related]
6. Chronic cerebral vasospasm: effect of volume and timing of hemorrhage in a canine model.
Zabramski JM; Spetzler RF; Bonstelle C
Neurosurgery; 1986 Jan; 18(1):1-6. PubMed ID: 3945370
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of basilar artery spasm after experimental subarachnoid hemorrhage in rabbit by potassium channel activator cromakalim--a preliminary result.
Kwan AL; Lin CL; Howng SL
Kaohsiung J Med Sci; 1999 May; 15(5):268-73. PubMed ID: 10375869
[TBL] [Abstract][Full Text] [Related]
8. Prevention of cerebral vasospasm after SAH with a thromboxane synthetase inhibitor, OKY-1581.
Sasaki T; Wakai S; Asano T; Takakura K; Sano K
J Neurosurg; 1982 Jul; 57(1):74-82. PubMed ID: 7201009
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage.
Seifert V; Eisert WG; Stolke D; Goetz C
Neurosurgery; 1989 Oct; 25(4):590-8. PubMed ID: 2507953
[TBL] [Abstract][Full Text] [Related]
10. Alterations of mechanical properties in canine basilar arteries after subarachnoid hemorrhage.
Kim P; Sundt TM; Vanhoutte PM
J Neurosurg; 1989 Sep; 71(3):430-6. PubMed ID: 2769393
[TBL] [Abstract][Full Text] [Related]
11. Subarachnoid hemorrhage and cerebrovascular spasm. Morphological study of intracranial arteries based on animal experiments and human autopsies.
Eldevik OP; Kristiansen K; Torvik A
J Neurosurg; 1981 Dec; 55(6):869-76. PubMed ID: 7299462
[TBL] [Abstract][Full Text] [Related]
12. Cerebral vasospasm after subarachnoid hemorrhage.
Chyatte D; Sundt TM
Mayo Clin Proc; 1984 Jul; 59(7):498-505. PubMed ID: 6376963
[TBL] [Abstract][Full Text] [Related]
13. Possible cellular mechanism for cerebral vasospasm after experimental subarachnoid hemorrhage in the dog.
Harder DR; Dernbach P; Waters A
J Clin Invest; 1987 Sep; 80(3):875-80. PubMed ID: 2957393
[TBL] [Abstract][Full Text] [Related]
14. Effect of the nonglucocorticoid 21-aminosteroid U74006F experimental cerebral vasospasm.
Vollmer DG; Kassell NF; Hongo K; Ogawa H; Tsukahara T
Surg Neurol; 1989 Mar; 31(3):190-4. PubMed ID: 2922661
[TBL] [Abstract][Full Text] [Related]
15. Cerebral arterial constriction after experimental subarachnoid hemorrhage is associated with blood components within the arterial wall.
Liszczak TM; Varsos VG; Black PM; Kistler JP; Zervas NT
J Neurosurg; 1983 Jan; 58(1):18-26. PubMed ID: 6847905
[TBL] [Abstract][Full Text] [Related]
16. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH
J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine A reduces cerebral vasospasm after subarachnoid hemorrhage in dogs.
Peterson JW; Nishizawa S; Hackett JD; Bun T; Teramura A; Zervas NT
Stroke; 1990 Jan; 21(1):133-7. PubMed ID: 2300980
[TBL] [Abstract][Full Text] [Related]
18. Influence of blood volume on cerebrospinal fluid levels of arachidonic acid metabolites after subarachnoid hemorrhage: experimental study on the pathogenesis of cerebral vasospasm.
Seifert V; Stolke D; Kunz U; Resch K
Neurosurgery; 1988 Sep; 23(3):313-21. PubMed ID: 3147407
[TBL] [Abstract][Full Text] [Related]
19. Ebselen (DR3305) ameliorates delayed cerebral vasospasm in a canine two-hemorrhage model.
Watanabe T; Nishiyama M; Hori T; Asano T; Shimizu T; Masayasu H
Neurol Res; 1997 Oct; 19(5):563-5. PubMed ID: 9329038
[TBL] [Abstract][Full Text] [Related]
20. Relaxant effect of calcitonin gene-related peptide on cerebral arterial spasm induced by experimental subarachnoid hemorrhage in dogs.
Nozaki K; Uemura Y; Okamoto S; Kikuchi H; Mizuno N
J Neurosurg; 1989 Oct; 71(4):558-64. PubMed ID: 2795174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
